Page 32 - MemoriaBBN-Eng

SCIENTIFIC PROGRAMMES

Development of a universal multiplexed diagnostic
OLIGOCODES
platform based on encoded oligonucleotide

nanoparticles and DNA sensor devices.

Coordinating PI: Pilar Marco. / Participating PIs: F. Albericio, R.
Eritja, J. Samitier, I. Obieta, external clinical groups.

Nanoparticles as new tools to fight HIV transmission.
GLYCO-HIV
Coordinating PI: Soledad Penadés. / Participating PIs: F. Albericio,
external groups.

Nanobioanalytical platforms to improve medical diagnosis
NANOMEDIAG
of infections caused by pathogenic microorganisms.

Coordinating PI: Josep Samitier. / Participating PIs: P. Marco, M. L.
González.

Development of new nanoparticles and protocols for
NANOHYPER-
enhanced hyperthermia.
THERMIA
Coordinating PI: Francisco del Pozo. / Participating PIs: E.
Fernández, S. Penadés, J. Santamaría, N. Vilaboa, R. Martínez. F.

Palacio (external group, CSIC).

New orthotopic/ectopic nude mice model of human thyroid
CELL-NANO- undifferentiated/anaplastic carcinoma: useful tool for new
THYROID
cell therapies, drug testing and validation in humans.

Coordinating PI: Alberto de Leiva. / Participating PIs: S. Schwartz,
J. L. Pedraz, R. Mangues, J. Blanco.

NANORETINA
Nanoscaffolds for relocating a detached retina.
Coordinating PI: Francisco del Pozo. / Participating PIs: J. Aguiló,
J. Veciana, external clinical groups.
é

New nanoparticles with molecular gates for diagnosis and
BIOGATES
drug delivery.
Coordinating PI: Ramón Martínez. / Participating PIs: R. Eritja, P.

Marco, S. Penadés, JL. Peris, S. Schwartz, M. Vallet.
ññ

Advanced diagnostic tool for the early identification of renal
LIVERPOC
failure. óó
ó
Coordinating PI: Laura Lechuga. / Participating PIs: P. Marco, M.
Doblar, external clinical group.
ó
á
Development and biological evaluation of multifunctional
METALOTRIGGER
carriers sensitive to metalloproteinase for combined

therapy for advanced colorectal cancer.
Coordinating PI: Sim Schwartz. / Participating PIs: F. Albericio.

Nucleic acid derivatives as potential drugs.
NADD
Coordinating PI: Ramn Eritja. / Participating PIs: R. Gómez, C.
Solans, MA. Muoz, JL Pedraz, F. Albericio.

13
NANOBICIDE
New nano approaches for microbicidal HIV drugs.
20
Coordinating PI: Rafael Gmez. / Participating PIs: R. Gómez, C. T
Solans, MA. Muoz, E. Fernndez.
R
PO
E
NANOFABRY
Development of nanomedicines for enzyme replacement L R
therapies in Fabry’s disease.
óA
Coordinating PI: Sim Schwartz. / Participating PIs: F. Albericio, F. NU
N
Sanz, J. Veciana, A. Villaverde, R. Mangues.
A
/
Development of electrophoretic and photonic techniques for BN
NANOPHOR
identifying and monitoring pathogenic microbes.
B
R-
Coordinating PI: F. del Pozo. / Participating PIs: J. Aguil, L. Roa, BE
external groups.
CI

32